Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570336 · ClinicalTrials.gov registry record · Phase 2
Study of CTS-1027 in Hepatitis C Patients
A Phase 2 study, sponsored by Conatus Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 87
- Enrollment target
NCT00570336 is a Phase 2 study that has completed, run by Conatus Pharmaceuticals. The registered enrollment target is 87 participants.
The verdict
NCT00570336, a Phase 2 study, has completed, sponsored by Conatus Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if CTS-1027 can lower elevated liver enzymes in patients with chronic HCV infection.
Interventions
- OTHER Placebo
- DRUG CTS-1027
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00570336
The ClinicalTrials.gov registry entry for NCT00570336 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Conatus Pharmaceuticals, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00570336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00570336 about?
NCT00570336 is a clinical study titled "Study of CTS-1027 in Hepatitis C Patients". The purpose of this study is to determine if CTS-1027 can lower elevated liver enzymes in patients with chronic HCV infection.
What is the current status of trial NCT00570336?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 87 participants. The study started on 2007-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00570336?
The interventions under investigation include: Placebo (OTHER), CTS-1027 (DRUG).
Who is sponsoring clinical trial NCT00570336?
This trial is sponsored by Conatus Pharmaceuticals, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.